Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients

Clinical trial NCT00730769 · COMPLETED

Trial details

NCT number: NCT00730769
Sponsor: Salvador Gil-Vernet
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Cytomegalovirus Infection

Start date: 2004-03-01
Primary completion: 2007-07-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.